Butterfly Network Inc
Change company Symbol lookup
Select an option...
BFLY Butterfly Network Inc
YALA Yalla Group Ltd
SEER Seer Inc
ITCI Intra-Cellular Therapies Inc
VZ Verizon Communications Inc
TISI Team Inc
PRTK Paratek Pharmaceuticals Inc
KIRY Kiewit Royalty Trust
OCAXW OCA Acquisition Equity Warrant Exp 14 Jan 2026 *W EXP 01/31/2028
ABBV Abbvie Inc
Go

Company profile

Butterfly Network, Inc., formerly Longview Acquisition Corp., is a digital health company. The Company is principally engaged in offering medical imaging system, Butterfly iQ. The Butterfly iQ is a handheld, single probe, whole-body ultrasound system, which uses semiconductor technology. The Company's products are powered by its Ultrasound-on-Chip technology, which is an ultrasound transducer that can perform whole-body imaging. Its ultrasound system is comprised of both hardware and software solutions designed to make ultrasound imaging accessible to all healthcare practitioners, including nurses, midwives and ultimately patients directly. Butterfly iQ is commercially available in approximately 20 countries, including the United States, Canada, Australia, New Zealand and Europe. The Company also has an eCommerce Website through which it sells its Butterfly iQ+ to healthcare practitioners. Its Butterfly iQ+ connects to a smart phone or tablet to perform ultrasound scans.

Price
Delayed
$7.71
Day's Change
0.24 (3.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.79
Day's Low
7.64
Volume
(Heavy Day)

Today's volume of 878,397 shares is on pace to be much greater than BFLY's 10-day average volume of 3,843,572 shares.

878,397

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATIP, SPPI and NNOX

4:45 pm ET October 11, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / October 11, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II (NYSE:ATIP)

This lawsuit is on behalf of investors who: (a) purchased or otherwise acquired ATI securities between February 22, 2021 and July 23, 2021, inclusive and/or (b) held FVAC Class A common stock as of May 24, 2021 and were eligible to vote at FVAC's June 15, 2021 special meeting.

Lead Plaintiff Deadline: October 15, 2021

According to the complaint, ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) ATI was experiencing attrition among its physical therapists; (2) ATI faced increasing competition for clinicians in the labor market; (3) as a result of the foregoing, the Company faced difficulties retaining therapists and incurred increased labor costs; (4) as a result of the labor shortage, the Company would open fewer new clinics; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in ATIP: https://www.kleinstocklaw.com/pslra-1/ati-physical-therapy-inc-f-k-a-fortress-value-acquisition-corp-ii-loss-submission-form?id=20311&from=1

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

Class Period: December 27, 2018 - August 5, 2021

Lead Plaintiff Deadline: November 1, 2021

The SPPI lawsuit alleges that throughout the class period, Spectrum Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the manufacturing facility for ROLONTIS, an investigational granulocyte-colony stimulating factor analog, maintained deficient controls and/or procedures; (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration would approve the ROLONTIS biologics license application ("BLA") in its current form; (iii) Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in SPPI: https://www.kleinstocklaw.com/pslra-1/spectrum-pharmaceuticals-inc-loss-submission-form?id=20311&from=1

Nano-X Imaging Ltd. (NASDAQ:NNOX)

Class Period: June 17, 2021 - August 18, 2021

Lead Plaintiff Deadline: December 6, 2021

Nano-X Imaging Ltd. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Nano-X's 510(k) application for the Nanox.ARC was deficient; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the 510(k) application for the Nanox.ARC in its current form; (iii) as a result, NanoX had overstated the Nanox.ARC's regulatory and commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in NNOX: https://www.kleinstocklaw.com/pslra-1/nano-x-imaging-ltd-loss-submission-form-2?id=20311&from=1

Image: https://www.accesswire.com/users/newswire/images/667635/Klein-Logos_CTA-Logo-3.png

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com

SOURCE: The Klein Law Firm

View source version on accesswire.com:

https://www.accesswire.com/667635/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-ATIP-SPPI-and-NNOX

comtex tracking

COMTEX_394965685/2457/2021-10-11T16:45:32

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.